Coagulation factors are protein components of the blood which serve blood coagulation.
Search results 51 to 75 from a total of 87
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|---|---|---|---|
|
Haemate P 250 I.E. FVIII / 600 I.E. VWF |
CSL Behring GmbH |
2416.00.00 | 08.06.1982 | |
|
Fibryga |
Octapharma GmbH |
PEI.H.11879.01.1 | 23.06.2017 | |
|
Fibrogammin 1250 |
CLS Behring GmbH |
PEI.H.03242.02.1 | 07.02.2005 | |
|
Fibrogammin 250 |
CSL Behring GmbH |
PEI.H.03242.01.1 | 07.02.2005 | |
|
FibCLOT |
Laboratoire Français du Fractionnement et des Biotechnologies, F Les Ulis |
PEI.H.11771.01.1 | 05.02.2016 | |
|
Fanhdi 1500 I.E. |
Grifols Deutschland GmbH |
PEI.H.03436.01.1 | 24.08.2006 | |
|
Fanhdi 1000 I.E. |
Grifols Deutschland GmbH |
10565a/97-3 | 12.08.1999 | |
|
Fanhdi 500 I.E. |
Grifols Deutschland GmbH |
10565a/97-2 | 12.08.1999 | |
|
Fanhdi 250 I.E. |
Grifols Deutschland GmbH |
10565a/97-1 | 12.08.1999 | |
|
Faktor VIII SDH INTERSERO 1000 |
Intersero GmbH |
16844.02.00 | 06.11.1991 | |
|
Faktor VIII SDH INTERSERO 500 |
Intersero GmbH |
16844.01.00 | 06.11.1991 | |
|
Faktor VIII SDH INTERSERO 250 |
Intersero GmbH |
16844.00.00 | 06.11.1991 | |
Esperoct |
Novo Nordisk A/S, Dänemark |
EU/1/19/1374 | 20.06.2019 | |
|
Elocta |
Swedish Orphan Biovitrum AB (publ) |
EU/1/15/1046 | 19.11.2015 | |
Cofact 500 |
Prothya Biosolutions Netherlands B.V. |
PEI.H.03453.02.1 | 31.08.2007 | |
|
Coagadex |
Bio Products Laboratory Ltd., UK-Hertfordshire |
EU/1/16/1087 | 16.03.2016 | |
|
Cluvot 1250 I.E. |
CSL Behring GmbH |
PEI.H.11666.02.1 | 07.03.2014 | |
|
Cluvot 250 I.E. |
CSL Behring GmbH |
PEI.H.11666.01.1 | 07.03.2014 | |
Cevenfacta |
Laboratoire francais du Fractionement et des Biotechnologies, Frankreich |
EU/1/22/1664 | 15.07.2022 | |
|
Beriplex P/N 1000 |
CSL Behring GmbH |
10501a/95a | 26.01.2013 | |
|
Beriplex P/N 500 |
CSL Behring GmbH |
10501a/95 | 21.02.1996 | |
|
Beriplex P/N 250 |
CSL Behring GmbH |
10500a/95 | 21.02.1996 | |
|
Beriate 2000 |
CSL Behring GmbH |
10505a/98-4 | 11.12.2012 | Rote-Hand-Brief: Beriate (09.08.2019) |
Beriate 2000 |
Orifarm GmbH |
PEI.H.12092.02.1 | 19.04.2021 | |
Beriate 2000 |
CC-Pharma GmbH |
PEI.H.12077.01.1 | 10.03.2021 |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 25.04.2025
